Matrix Capital Management Company, LP → Aura Biosciences, Inc. AURA

Stake: — Shares: 0 Class: Common Stock, par value $0.00001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 9.23

10,366,122 shares short · +47.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $298K

Point72 Asset Mgmt

Post-Filing Returns · since 2026-05-07 on AURA

+1 day

+2.4%

+5 days

-3.3%

+30 days

-21.0%

+60 days

-13.5%

+90 days

—

+180 days

—

Anchor price 8.20 on closest trading day on/after 2026-05-07. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Aura Biosciences, Inc.

Filed	Form	Filer	Stake	Shares
2026-10-01	SCHEDULE 13G	ForGrowth III PA B.V.	—	—	view →
2025-05-19	SCHEDULE	Matrix Capital Management Company, LP	11.17%	6,922,870	view →

Other Filings by Matrix Capital Management Company, LP

Filed	Form	Issuer	Stake	Shares
2026-01-02	SCHEDULE	Zentalis Pharmaceuticals, Inc. ZNTL	—	—	view →
2025-05-19	SCHEDULE	Aura Biosciences, Inc. AURA	11.17%	6,922,870	view →
2023-06-20	SC	Zentalis Pharmaceuticals, Inc. ZNTL	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →